Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Triptorelin

Decapeptyl, Trelstar, Gonapeptyl, Pamorelin

A synthetic GnRH agonist decapeptide that suppresses gonadotropin and sex hormone production for treating prostate cancer, endometriosis, and precocious puberty.

Quick Stats
Studies 178
Trials 100
Formula C64H82N18O13
Clear All
Completed PHASE4 NCT01581359

The Effect of Pre-treatment With GnRH Analogues Prior in Vitro Fertilization in Patients With Endometriosis

Instituto de Investigacion Sanitaria La Fe
INTERVENTIONAL
Updated Dec 15, 2025
Unknown PHASE2 NCT03475758

Goserelin for Ovarian Protection in Premenopausal Patients Receiving Cyclophosphamide

Assiut University
INTERVENTIONAL
Updated Dec 15, 2025
Completed PHASE2 NCT01969578

Androgen Deprivation Therapy in Advanced Salivary Gland Cancer

European Organisation for Research and Treatment of Cancer - EORTC
INTERVENTIONAL
Updated Dec 15, 2025
Completed NCT04174378

Luteal Phase Support In IVF Women Using GnRH Agonist

National University of Malaysia
OBSERVATIONAL
Updated Dec 15, 2025
Completed PHASE4 NCT02185326

Microflare Protocol in Poor Responders

Woman's Health University Hospital, Egypt
INTERVENTIONAL
Updated Dec 15, 2025
Unknown PHASE4 NCT00438217

Analysis of Genetic and Environmental Parameters Influencing Growth Rate of Precocious Puberty Children

University of Pisa
INTERVENTIONAL
Updated Dec 15, 2025
Completed PHASE3 NCT03039049

GNRH Agonist Trigger and Modified Luteal Phase Adding a Bolus of GnRHa at the Time of Implantation: a RCT

Centre Hospitalier Universitaire Ibn Rochd
INTERVENTIONAL
Updated Dec 15, 2025
Completed PHASE4 NCT03115307

Luteal Phase Support in Insemination Cycles

Tampere University Hospital
INTERVENTIONAL
Updated Dec 15, 2025
Completed PHASE2 NCT01790126

The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer

Aragon Pharmaceuticals, Inc.
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting NA NCT05945407

Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer

Peking University People's Hospital
INTERVENTIONAL
Updated Dec 15, 2025
Completed NCT05969834

HCG Levels After Ovulation Triggering as Predictors of ICSI Outcome

Mansoura University
OBSERVATIONAL
Updated Dec 15, 2025
Recruiting PHASE2, PHASE3 NCT04356664

Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis

Hopital Foch
INTERVENTIONAL
Updated Dec 15, 2025
Completed PHASE2 NCT02005887

TRial on the Endocrine Activity of Neoadjuvant Degarelix

ETOP IBCSG Partners Foundation
INTERVENTIONAL
Updated Dec 15, 2025
Completed EARLY PHASE1 NCT04130152

Palbociclib Plus Letrozole in Hormone Receptor Positive Residual Disease After Neoadjuvant Chemotherapy

SOLTI Breast Cancer Research Group
INTERVENTIONAL
Updated Dec 15, 2025
Terminated NCT04454749

Endometrial Compaction and Its Influence on Pregnancy Rate in Frozen Embryo Cycle Regimes

ART Fertility Clinics LLC
OBSERVATIONAL
Updated Dec 15, 2025
Unknown NA NCT05838105

Two Different Types of Luteal Phase Support in Natural Cycle Frozen Embryo Transfer and Its Effect on Pregnancy Rates

Shaare Zedek Medical Center
INTERVENTIONAL
Updated Dec 15, 2025
Completed NA NCT00516490

GnRH Agonist Administration in the Luteal Phase of ICSI-ET Cycles

V.K.V. American Hospital, Istanbul
INTERVENTIONAL
Updated Dec 15, 2025
Completed PHASE3 NCT00909844

Effects of Triptorelin Pamoate in Children With Precocious Puberty - Follow up Study

Ipsen
INTERVENTIONAL
Updated Dec 15, 2025